Phototherapy method and device

Patent metadata

Field	Value
Publication number	US-9636522-B2
Application number	US-201113814599-A
Country	US
Kind code	B2
Filing date	Aug 4, 2011
Priority date	Aug 11, 2010
Publication date	May 2, 2017
Grant date	May 2, 2017

Abstract

A method of biostimulating phototherapy is provided. The method comprises illuminating a subject's body portion ( 1 ) with light having a first wavelength in the range of 600-900 nm ( 17 ) and reducing and preventing hyperthermia of the body portion by illuminating the body portion with light having a second wavelength which is at least one of in the range of 400-600 nm and in the range of 900-2500 nm ( 19 ). Further, a phototherapy device ( 21 ) is provided which comprises a first light source ( 25 ) and a second light source ( 26 ). The first light source is configured to emit light ( 17 ) having a first wavelength which is in the range of 600-900 nm. The second light source is configured to emit light ( 19 ) having a second wavelength which is at least one of in the range of 400-600 nm and in the range of 900-2500 nm.

First claim

The invention claimed is:

1. A method of operating a phototherapy device for bio-stimulation of skin,
the method comprising:
illuminating, via one or more first light sources, a body portion with light having a first wavelength in a range of 600-900 nm, and
illuminating, via one or more second light sources, the body portion with light having a second wavelength, the second wavelength within one of ranges of: 400-600 nm, and 900-2500 nm;
determining via a controller, melanin-index dependent irradiance correction factor based on a concentration of melanosomes in the body portion, a wavelength dependent absorption of melanin and an optical path in the body portion;
determining via the controller, a first intensity, associated with the first wavelength, and a second intensity, associated with the second wavelength, based on the determined melanin-index dependent irradiance correction factor,
monitoring by the controller via a thermal sensor, a temperature of the illuminated body portion, and
adjusting via the controller, at least one of the second intensity and a dose of the light having the second wavelength, to operate in the second wavelength providing superficial heating of the body portion in response to the monitored temperature of the body portion.

2. The method of claim 1 , wherein a portion of the illuminating of the body portion with the second wavelength is performed prior to a portion of the illuminating of the body portion with the light having the first wavelength.

3. The method of claim 1 , wherein illuminating the body portion with the second wavelength comprises administering a plurality of doses of light with the second wavelength.

4. The method of claim 1 , comprising:
administering a plurality of doses of light with the first wavelength, and
administering a plurality of doses of light with the second wavelength to the body portion, wherein at least a portion of the doses of light with the second wavelength precedes the one or more doses of light with the first wavelength.

5. The method of claim 4 , wherein administrating a dose of light with the second wavelength is timed as a function of one or more properties of the body portion being illuminated.

6. A method of bio-stimulating using a phototherapy device,
the method comprising:
controlling, by a controller, at least one light source to illuminate a subject's body portion with light having a first wavelength in a range of 600-900 nm, and illuminate the body portion with light having a second wavelength within one of ranges of: 400-600 nm and 900-2500 nm,
determining, by the controller, a melanin-index dependent irradiance correction factor associated with skin of the subject's body portion based on a concentration of melanosomes in the body portion, a wavelength dependent absorption of melanin and an optical path of light in the body portion,
adjusting, by the controller, at least one of: an intensity and a dose of the light of at least one of: the first wavelength and the second wavelength based on the melanin-index dependent irradiance correction factor,
monitoring by the controller communicating with a thermal sensor, a temperature of the skin of the body portion; and
adjusting the illumination of the second light based on the monitored temperature, wherein the second light is operated with the second wavelength to provide superficial heating of the body portion dependent on the temperature of the body portion.

7. The method of claim 1 , wherein the melanin-index dependent irradiance correction factor (Icf) uses the equation
Icf=exp(Cm μ(λ) d,

where Cm is a measured of the concentration of melanosomes in the epidermis of the skin portion, μ(λ) relates to wavelength dependent absorption of melanin, and d relates to an optical path in the epidermis.

8. A computer-readable storage-medium that is not a transitory propagating signal or wave, the medium comprising control instructions for controlling an operation of a phototherapy device for bio-stimulation of skin, the instructions comprising:
illuminating, via one or more first light sources, a body portion with light having a first wavelength in a range of 600-900 nm;
illuminating, via one or more second light sources, the body portion with light having a second wavelength, the second wavelength within one of ranges of: 400-600 nm, and 900-2500 nm;
determining via a controller, melanin-index dependent irradiance correction factor based on a concentration of melanosomes in the body portion, a wavelength dependent absorption of melanin and an optical path in the body portion; and
determining via the controller, a first intensity, associated with the first wavelength, and a second intensity, associated with the second wavelength, based on the determined melanin-index dependent irradiance correction factor;
monitoring by the controller via a thermal sensor, a temperature of the illuminated body portion; and
adjusting via the controller, at least one of the second intensity and a dose of the light having the second wavelength to operate at the second wavelength providing superficial heating of the body portion in response to the monitored temperature of the body portion.

9. A phototherapy device for bio-stimulating skin, and comprising:
a controller configured to control at least one light source to illuminate a subject's body portion with light having a first wavelength in a range of 600-900 nm, and illuminate the body portion with light having a second wavelength within one of ranges of: 400-600 nm and 900-2500 nm,
the controller configured to determine a melanin- index dependent irradiance correction factor associated with skin of the subject's body portion based on a concentration of melanosomes in the body portion, a wavelength dependent absorption of melanin and an optical path of light in the body portion,
the controller configured to adjust at least one of: an intensity and a dose of the light of at least one of: the first wavelength and the second wavelength based on the melanin-index dependent irradiance correction factor,
a thermal sensor configured for sensing the skin temperature of the body portion
the controller configured to communicate with a thermal sensor for monitoring the temperature of the skin of the body portion; and
the controller configured to adjust the illumination of the second light based on the monitored temperature, wherein the second light is operated with the second wavelength to provide superficial heating of the body portion depending on the temperature of the body portion.

10. The phototherapy device of claim 9 , wherein the controller is configured to adjust at least one of: an intensity and a dose of the light of at least one of: the first wavelength at least partially independent of adjustment of the second wavelength.

11. The phototherapy device of claim 9 , wherein the controller is configured for performing a portion of the illuminating of the body portion with the second wavelength prior to performing a portion of the illuminating of the body portion with the light having the first wavelength.

12. The phototherapy device of claim 9 , the controller is configured to control the illumination of the body portion with the second wavelength by administering a plurality of doses of light with the second wavelength.

13. The phototherapy device of claim 9 , the controller is configured to:
administer a plurality of doses of light with the first wavelength to the body portion, and
administer a plurality of doses of light with the second wavelength to the body portion, wherein at least a portion of the doses of light with the second wavelength precedes the one or more dose

Assignees

• Oversluizen Gerrit
• Van Abeelen Frank Anton
• Van Pieterson Liesbeth
• Zhou Guofu
• Dekker Tim
• Koninklijke Philips Nv

Inventors

• Oversluizen Gerrit
• Van Abeelen Frank Anton
• Van Pieterson Liesbeth
• Zhou Guofu
• Dekker Tim

Classifications

• A61N2005/0628

  including a radiation sensor · CPC title

• A61N5/0616 Primary

  Skin treatment other than tanning · CPC title

• A61N2005/0645

  Applicators worn by the patient · CPC title

• A61N2005/0659

  infrared · CPC title

• A61N2005/0662

  Visible light · CPC title